InfuSystem Holdings, Inc.
INFUCIK 0001337013
Revenue (TTM)
$140.89M
+6.4% YoY
Q1 May 2026
Net Income (TTM)
$5.61M
+182.6% YoY
Q1 May 2026
EPS Diluted (TTM)
$0.27
+181.8% YoY
Q1 May 2026
Gross Margin
56.5%
Q1 May 2026
Operating Margin
7.0%
Q1 May 2026
Net Margin
4.0%
Q1 May 2026
Free Cash Flow (TTM)
$2.19M
Q1 May 2026
Cash
$2.11M
Q1 May 2026
Total Debt
$19.65M
Q1 May 2026
Shares Outstanding
20.18M sh
Q1 May 2026